Patent · US Expired

3(5)-Heteroaryl substituted pyrazoles as p38 kinase inhibitors

US6335336B1 · kind B1 · utility

7Cited by
9References
47Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 28, 2000
Grant dateJan 1, 2002
Priority date—
Expiry dateApr 28, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.